stockrow
Saturday 7 November 2026
Export SVRA’s income statement to Excel — free account
Savara Inc.
SVRA Healthcare Biotechnology
- EPS
- −14.3%
- Free cash flow
- −14.1%
- Total debt
- +1.54%
Quarter to June 2026, against a year earlier
4.83
0.45
+10.27%
Follow SVRA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
7.42 | 11.56 | 13.05 | 9.83 | |
Current Ratio |
7.65 | 11.85 | 13.47 | 10.13 | |
Net Debt/EBITDA |
3.10 | 6.10 | 4.39 | 3.47 | |
Debt/Assets |
21.13% | 11.80% | 13.57% | 15.67% | |
Debt/Equity |
0.32 | 0.15 | 0.17 | 0.21 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.78 | 0.89 | 0.74 | |
Capex/Depreciation |
0.01 | 0.01 | 0.16 | 0.79 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.10) | (0.11) | (0.13) | (0.12) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.10) | (0.11) | (0.13) | (0.12) | |
Cash per Share |
0.57 | 1.06 | 0.80 | 0.68 | |
Shareholders Equity per Share |
0.44 | 0.91 | 0.70 | 0.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.44 | 0.91 | 0.70 | 0.57 | |
Free Cash Flow |
(22.53) | (25.06) | (33.10) | (29.97) | |
Working Capital |
111.44 | 221.22 | 193.73 | 160.72 | |
Capital Expenditures |
0.00 | 0.00 | (0.05) | (0.22) | |
Net Current Asset Value |
81.66 | 191.31 | 163.66 | 129.84 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
4.37 | 5.15 | 5.03 | 5.87 | |
Average Assets |
189.87 | 233.16 | 205.48 | 177.95 | |
Average Common Equity |
146.87 | 187.29 | 161.94 | 132.07 |
Columns are period end dates · fundamentals updated 25 Oct 2026